Carregant...
An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn’s Disease
INTRODUCTION: Real-world treatment persistence to ustekinumab for Crohn’s disease (CD) was studied using Australian Pharmaceutical Benefits Scheme (PBS) data. Demographic and treatment pattern characteristics were also investigated. METHODS: Our retrospective cohort analysis included PBS 10% sample...
Guardat en:
| Publicat a: | Biologics |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8215905/ https://ncbi.nlm.nih.gov/pubmed/34163137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S310076 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|